麻豆传媒

Filters close
Go to Advanced Search
麻豆传媒: Metabolic Shift in Liver Cancer: How PDHX Acetylation Drives Tumor Growth
Released: 3-Mar-2025 5:50 AM EST
Metabolic Shift in Liver Cancer: How PDHX Acetylation Drives Tumor Growth
Chinese Academy of Sciences

A recent study has unveiled a new mechanism driving hepatocellular carcinoma (HCC) progression through the acetylation of pyruvate dehydrogenase complex (PDC) component X (PDHX), a critical component of the PDC. This modification disrupts PDC assembly, inhibits its function, and shifts metabolism towards aerobic glycolysis, promoting tumor growth. The findings highlight PDHX acetylation as both a potential biomarker and therapeutic target, offering new possibilities for liver cancer treatment and advancing our understanding of cancer cell metabolism.

Released: 2-Mar-2025 4:00 PM EST
Sleep Apnea Linked to Increased Risk of Parkinson鈥檚, but CPAP May Reduce Risk
American Academy of Neurology (AAN)

People with obstructive sleep apnea have an increased risk of Parkinson鈥檚 disease, but if started early enough, continuous positive airway pressure (CPAP) may reduce that risk, according to a preliminary study released today, March 2, 2025, that will be presented at the American Academy of Neurology鈥檚 77th Annual Meeting taking place April 5鈥9, 2025, in San Diego and online. The study found using CPAP within two years of a sleep apnea diagnosis reduced the risk of Parkinson鈥檚.

麻豆传媒: UniSA Sports Science Hub Welcomes First Student Cohort to New, World-Class Facility
Released: 2-Mar-2025 3:30 PM EST
UniSA Sports Science Hub Welcomes First Student Cohort to New, World-Class Facility
University of South Australia

It鈥檚 the multi-million-dollar sports complex, 15 years in the planning and two years to build, but today the UniSA Sport Science Hub opens its doors to its first cohort of university students ready to engage in its world-class teaching and research facilities at South Australia鈥檚 new sports precinct.

麻豆传媒: Johns Hopkins Medicine Study Shows How Recently Approved Drug for Food Allergies Compares to Oral Immunotherapy, Whether It Allows Patients to Eat Their Food Allergens
Released: 2-Mar-2025 2:00 PM EST
Johns Hopkins Medicine Study Shows How Recently Approved Drug for Food Allergies Compares to Oral Immunotherapy, Whether It Allows Patients to Eat Their Food Allergens
Johns Hopkins Medicine

New research, led by Johns Hopkins Children鈥檚 Center investigators and sponsored by the National Institutes of Health鈥檚 (NIH) National Institute of Allergy and Infectious Diseases (NIAID), finds that omalizumab, a U.S. Food and Drug Administration-approved (FDA) injectable drug for food allergies, performed better than oral immunotherapy. A subsequent phase of the study also found that patients may be able to introduce allergenic foods into their diets after stopping the medicine.

麻豆传媒: UP鈥檚 Prof De Wet Swanepoel Wins International Award for Hearing for Improving Access to Hearing Healthcare
Released: 1-Mar-2025 7:30 AM EST
UP鈥檚 Prof De Wet Swanepoel Wins International Award for Hearing for Improving Access to Hearing Healthcare
University of Pretoria

Professor De Wet Swanepoel of the Department of Speech-Language Pathology and Audiology at the University of Pretoria (UP) has received the International Award for Hearing from the American Academy of Audiology. Prof Swanepoel 鈥 who co-founded the hearX Group, a digital health company 鈥 received the award for his research that seeks to expand mobile hearing care to underserved areas locally and globally.

麻豆传媒: David M. Dines, MD, Receives Lifetime Achievement Award from Long Island Business 麻豆传媒
Released: 28-Feb-2025 7:40 PM EST
David M. Dines, MD, Receives Lifetime Achievement Award from Long Island Business News
Hospital for Special Surgery

David M. Dines, MD, a sports medicine surgeon at Hospital for Special Surgery and HSS Long Island, received the Lifetime Achievement Award from Long Island Business 麻豆传媒 at the publication's Health Care Heroes Awards ceremony on February 28.

麻豆传媒: Ochsner Health Marks 50,000 Robot-Assisted Surgeries
Released: 28-Feb-2025 7:30 PM EST
Ochsner Health Marks 50,000 Robot-Assisted Surgeries
Ochsner Health

Ochsner Health is proud to announce a groundbreaking milestone this month. 50,000 minimally invasive robot-assisted surgeries have been performed across the system.

麻豆传媒:Video Embedded top-5-facts-to-know-about-kidney-cancer-with-dr-saum-ghodoussipour2
VIDEO
Released: 28-Feb-2025 7:25 PM EST
Top 5 Facts to Know About Kidney Cancer with Dr. Saum Ghodoussipour
Rutgers Cancer Institute

The kidneys are two bean-shaped organs located just below the rib cage, one on each side of your spine. Healthy kidneys filter blood to remove waste and extra water to make urine. Kidney cancer, also known as renal cell carcinoma or RCC, forms when healthy cells in one or both kidneys grow out of control. March is Kidney Cancer Awareness Month. Learn more with Dr. Saum Ghodoussipour from Rutgers Cancer Institute and RWJBarnabas Health!

麻豆传媒: Rutgers鈥 Mobile Clinic: The Heartbeat of Health for Those Experiencing Homelessness
Released: 28-Feb-2025 7:25 PM EST
Rutgers鈥 Mobile Clinic: The Heartbeat of Health for Those Experiencing Homelessness
Rutgers University-New Brunswick

An expanding initiative between Newark and the Rutgers New Jersey Medical School is bringing health care 鈥 and hope 鈥 to the city鈥檚 unhoused population

麻豆传媒: St. Jude Scientists Solve Mystery of How the Drug Retinoic Acid Works to Treat Neuroblastoma
Released: 28-Feb-2025 7:15 PM EST
St. Jude Scientists Solve Mystery of How the Drug Retinoic Acid Works to Treat Neuroblastoma
St. Jude Children's Research Hospital

Why retinoic acid is effective in this setting but not against primary tumors, has been speculated about for nearly 50 years. St. Jude Children鈥檚 Research Hospital scientists resolved the mystery, showing the drug 鈥渉ijacks鈥 a normal developmental pathway to trigger cancer cell death.

麻豆传媒: Illinois Researchers Develop Next-Generation Organic Nanozymes and Point-of-Use System for Food and Agricultural Uses
Released: 28-Feb-2025 7:10 PM EST
Illinois Researchers Develop Next-Generation Organic Nanozymes and Point-of-Use System for Food and Agricultural Uses
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

A University of Illinois Urbana-Champaign research team has developed organic-material-based nanozymes that are non-toxic, environmentally friendly, and cost effective. In two new studies, they introduce next-generation organic nanozymes and explore a point-of-use platform for molecule detection in agricultural products.



close
4.69898